Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Peru

- PMLiVE

Takeda buys vaccines specialist Inviragen

Acquires vaccine candidates against dengue fever and hand, foot and mouth disease in $250m deal

- PMLiVE

US-based Millennium launches blood cancer website

The Takeda Oncology Company roll out new multiple myeloma website

- PMLiVE

Current development and marketing of biosimilar monoclonal antibodies in Latin America

An in-depth table of biosimilar products in the region

Unfolding the biosimilar landscape in Latin America

Cost containment and safety concerns mean an ongoing tussle between payers and regulators, with the latter gaining the upper hand

- PMLiVE

Pharma companies partner with Japanese government

GHIT Fund will support development of medicines for infectious diseases in developing countries

- PMLiVE

Takeda files lymphoma drug brentuximab vedotin in Japan

Seeks approval for antibody-drug conjugate for two forms of the blood cancer

- PMLiVE

Takeda suspended as vice president of Japanese industry body

Mis-labelling also prompts JPMA to takes action against CMO Nihon Pharmaceutical

- PMLiVE

Takeda files IBD drug vedolizumab in Europe

Potential safer alternative to TNF blockers like Remicade and Humira

- PMLiVE

Takeda-Affymax recall Omontys in US after deaths

Severe allergic reactions reported in kidney disease patients taking anaemia drug

Product updates from Japan

New approvals and filings include drugs from Takeda, Otsuka, Chugai and Astellas

Oscar Ferenczi joins Grünenthal from Sandoz

Will lead German pharma company's Latin American expansion plans

- PMLiVE

BMS licenses OTC rights to Reckitt for $482m

Will market products including Picot, Tempra and Graneodin in Latin America

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links